Home › Renal Insufficiency
Renal Insufficiency clinical trials recruiting in the U.S.
26 studies for Renal Insufficiency are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA7 studies
- Houston, TX6 studies
- Orlando, FL5 studies
- Philadelphia, PA4 studies
- Hialeah, FL4 studies
- Durham, NC4 studies
- Dallas, TX4 studies
- New York City, NY3 studies
- Tampa, FL3 studies
- Raleigh, NC3 studies
- Rochester, MN3 studies
- St. Louis, MO3 studies
- Queens, NY3 studies
- Phoenix, AZ3 studies
- New Haven, CT3 studies
- Nashville, TN3 studies
- Seattle, WA3 studies
- Omaha, NE3 studies
- Cedar Rapids, IA3 studies
- Ann Arbor, MI3 studies
- Davie, FL3 studies
By state
- Alabama3 studies
- Arizona3 studies
- California7 studies
- Connecticut3 studies
- Florida13 studies
- Georgia5 studies
- Illinois3 studies
- Iowa3 studies
- Kentucky3 studies
- Maryland3 studies
- Massachusetts7 studies
- Michigan4 studies
- Minnesota4 studies
- Missouri4 studies
- Nebraska3 studies
- New Jersey3 studies
- New York6 studies
- North Carolina6 studies
- Ohio3 studies
- Pennsylvania6 studies
- South Carolina3 studies
- Tennessee6 studies
- Texas7 studies
- Washington3 studies
Recently updated studies
Delayed Tolerance Through Mixed Chimerism
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT05900401A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05805709Concomitant Renal and Urinary Bladder Allograft Transplantation
RecruitingEarly phase 1
Ages 1 to 60 · All sexes · Updated Sep 24, 2026 · NCT04626167A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Sep 23, 2026 · NCT07734610Product Surveillance Registry
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07741604Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Sep 4, 2026 · NCT07754331Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 6, 2026 · NCT06613568SPYRAL GEMINI Pilot Study
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jun 16, 2026 · NCT07559396CAR-T Cell Therapy for Desensitization in Kidney Transplantation
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated May 22, 2026 · NCT06056102A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated May 12, 2026 · NCT07315360Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Recruiting
Ages 60 and older · All sexes · Updated May 6, 2026 · NCT07446296Empagliflozin Treatment in Kidney Transplant Recipients
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865Shingrix in Renal Transplant Recipients
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Apr 8, 2026 · NCT04128189Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
Recruiting
Ages 22 to 85 · All sexes · Updated Mar 19, 2026 · NCT07017933Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
RecruitingEarly phase 1
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT06142396Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06623630SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Recruiting
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06001827Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 28, 2026 · NCT04240054Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 28, 2026 · NCT06752577A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Recruiting
Ages 18 to 90 · All sexes · Updated Dec 22, 2025 · NCT04671771Post-Filter Hematocrit
Recruiting
Ages 18 and older · All sexes · Updated Dec 19, 2025 · NCT07293936Prevent Cardiac Surgery Associated AKI Trial
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 8, 2025 · NCT06620523From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.